Table 4 COX survival analysis in different groups
From: Prognostic impact of PTK6 expression in triple negative breast cancer
parameter | LNM +  | LNM- | ||||
|---|---|---|---|---|---|---|
OS | P | DFS | P | DFS | P | |
HR(95%CI) | HR(95%CI) | HR(95%CI) | ||||
COX univariate survival analysis | ||||||
 PTK6 | 28.957 (0. 115–7280.0) | 0.233 | 4.665(1.116–19.507) | 0.035 | 0.937(0.249–3.534) | 0.924 |
 Age(y) | 3.454 (0.963–12.385) | 0.057 | 1.951(0.946–4.026) | 0.070 | 0.925(0.282–3.032) | 0.898 |
 Histological type | 0.881(0.197–3.937) | 0.868 | 0.922(0.356–2.389) | 0.868 | 1.188(0.348–4.059) | 0.783 |
 HER2 | 0.719(0.249–2.072) | 0.541 | 0.887(0.448–1.755) | 0.730 | 0.215(0.046–0.994) | 0.049 |
 T stage | 3.132(0.982–9.989) | 0.054 | 1.949(0.804–4.722) | 0.139 | 0.045(0.000–3138.2) | 0.587 |
 N stage | 4.853(1.521–15.482) | 0.008 | 2.498(1.257–4.967) | 0.009 | None | None |
 breast | 1.896(0.653–5.658) | 0.252 | 1.314(0.662–2.607) | 0.435 | 0.955(0.279–3.262) | 0.941 |
 Histological grading | 1.374(0.383–4.927) | 0.625 | 1.479(0.642–3.407) | 0.358 | 0.727(0.222–2.381) | 0.598 |
COX multifactor survival analysis | ||||||
 PTK6 |  |  | 4.507(1.077–18.856) | 0.039 |  |  |
 N stage |  |  | 2.432(1.223–4.839) | 0.011 |  |  |